Trials / Terminated
TerminatedNCT01902888
Evaluation of GORE® VIABAHN® Endoprosthesis for Popliteal Artery Aneurysm
Retrospective Evaluation of the GORE® VIABAHN® Endoprosthesis for a Popliteal Artery Aneurysm Indication
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, non-randomized, single arm, retrospective study of GORE® VIABAHN® Endoprosthesis for the treatment of a Popliteal Artery Aneurysm (PAA).
Detailed description
The primary objective is to evaluate the safety and efficacy of the GORE® VIABAHN® Endoprosthesis for the treatment of subjects with Popliteal Artery Aneurysms. The study population includes subjects with an asymptomatic aneurysm (≥ 2 cm diameter) of the popliteal artery, symptomatic aneurysm (no diameter requirement) of the popliteal artery, or presence of mural thrombus (no diameter requirement) of the popliteal artery treated with the GORE® VIABAHN® Endoprosthesis between January 1, 2002 and December 31, 2010. Starting with most recently treated within the above date range, patients meeting Inclusion/Exclusion will be enrolled, until a minimum of 50 subjects with adequate follow up to determine primary endpoints through 12 months will be provided.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GORE® VIABAHN® Endoprosthesis |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2013-07-18
- Last updated
- 2015-06-19
- Results posted
- 2015-06-19
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01902888. Inclusion in this directory is not an endorsement.